SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001013594-18-000386
Filing Date
2018-06-19
Accepted
2018-06-19 14:20:41
Documents
2

Document Format Files

Seq Description Document Type Size
1 JUNE 19, 2018 tonix13g-061918.htm SC 13G 68422
2 JOINT FILING AGREEMENT tonixex991-061918.htm EX-99.1 5926
  Complete submission text file 0001013594-18-000386.txt   76054
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Subject) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-86436 | Film No.: 18906868
SIC: 2834 Pharmaceutical Preparations

Mailing Address 152 WEST 57TH STREET 9TH FLOOR NEW YORK NY 10019
Business Address 152 WEST 57TH STREET 9TH FLOOR NEW YORK NY 10019 212-256-8402
REGALS CAPITAL MANAGEMENT LP (Filed by) CIK: 0001542838 (see all company filings)

IRS No.: 454228900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G